期刊
LIFE SCIENCES
卷 239, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.lfs.2019.117073
关键词
Breast Cancer; Centchroman; Ormeloxifene; Genistein; PI3K/Akt; Apoptosis
资金
- CSIR-Central Drug Research Institute, Lucknow, India [MLP-0750]
Aims: Recently, strategies of cancer treatment using combination of agents with distinct molecular mechanism (s) of action are considered more promising due to its high efficacy and reduced systemic toxicity. The study is aimed to improve the efficacy of selective estrogen receptor modulator, Centchroman (CC) by combination with the phytoestrogen Genistein (GN). Methods: Cytotoxicity was evaluated by Sulforhodamine B assay. Cell cycle analysis was done through flow cytometry. Further, Apoptosis was analyzed using Annexin V/PI staining, tunel assay and electron microscopic examination and verified using western blot analysis. In order to validate the in vitro results, in vivo analysis was performed using 4T1-syngeneic mouse model. Key findings: In this study, we report that the dietary isoflavone genistein (GN) synergistically improved anti-neoplasticity of CC in breast cancer by arresting cells at G2/M phase culminating in ROS dependent apoptosis. The combination of CC plus GN caused dysregulation of Bax and Bcl-2 ratio inducing mitochondrial dysfunction, activation of Caspase-3/7, -9 and PARP cleavage. Further, combination significantly suppresses phosphorylation of PI3K/Akt/NF-kappa B, enhancing apoptosis. Additionally, combination markedly reduced tumor growth compared to CC and GN alone in mouse 4T1 breast tumor model. Significance: Together, these studies suggest that GN represents a potential adjunct molecule whose role in CC induced apoptosis deserves attention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据